IBIO vs TECH · rev $100.0K vs P/E 65, rev $1.22B
iBio, Inc. Common Stock (IBIO) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
IBIO currently screens at market cap $13.4M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the IBIO and TECH stock pages for the full models.
Not investment advice.